Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-11-07
2006-11-07
Myers, Carla J. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S024310, C536S024320, C536S024330
Reexamination Certificate
active
07132235
ABSTRACT:
Detection of variable nucleotide(s) is based on primer extension and incorporation of detectable nucleoside triphosphates. By selecting the detection step primers from the region immediately adjacent to the variable nucleotide, this variation can be detected after incorporation of as few as one nucleoside triphosphate. Labelled nucleoside triphosphates matching the variable nucleotide are added and the incorporation of a label into the detection step primer is measured. The selection of the detection step primer is important to the method according to this invention and is dependent on the nucleotide sequence of interest. The detection step primers are preferably selected so as to span the region immediately toward the 3′ end from the variable nucleotide to be detected. The detection step primers can also be complementary to a sequence beginning several nucleotides removed from the variable nucleotide. The only limitation concerning the position of the detection step primers is that the sequence between the 3′ end of the detection step primer and the variable nucleotide to be detected must not contain a nucleotide residue of the same type as the one to be detected. The detection step primers can equally well be chosen to be complementary to either the coding or non-coding strands of the nucleotide sequence of interest.
REFERENCES:
patent: 4307189 (1981-12-01), Kit
patent: 4563419 (1986-01-01), Ranki et al.
patent: 4656127 (1987-04-01), Mundy
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4734363 (1988-03-01), Datagupta et al.
patent: 4760017 (1988-07-01), McCormick
patent: 4800159 (1989-01-01), Mullis et al.
patent: 4840892 (1989-06-01), Adams
patent: 4851331 (1989-07-01), Vary et al.
patent: 4863849 (1989-09-01), Melamede
patent: 4883750 (1989-11-01), Whiteley et al.
patent: 4962020 (1990-10-01), Tabor et al.
patent: 4968602 (1990-11-01), Dattagupta
patent: 5200314 (1993-04-01), Urdea
patent: 5221518 (1993-06-01), Mills
patent: 5310893 (1994-05-01), Erlich et al.
patent: 5476769 (1995-12-01), Soderlund et al.
patent: 5846710 (1998-12-01), Bajaj
patent: 5888819 (1999-03-01), Goelet et al.
patent: 6004744 (1999-12-01), Goelet et al.
patent: 6013431 (2000-01-01), Soderlund et al.
patent: 0123513 (1984-04-01), None
patent: 237362 (1987-09-01), None
patent: 0238332 (1987-09-01), None
patent: 0246864 (1987-11-01), None
patent: 0288737 (1988-11-01), None
patent: 0332435 (1989-03-01), None
patent: 0333465 (1989-03-01), None
patent: 0 329 311 (1989-08-01), None
patent: 329822 (1989-08-01), None
patent: 0357011 (1989-08-01), None
patent: 332435 (1989-09-01), None
patent: 336731 (1989-10-01), None
patent: 371437 (1989-11-01), None
patent: 03070694 (1989-11-01), None
patent: 0 374 665 (1990-06-01), None
patent: 0412883 (1991-03-01), None
patent: 2650840 (1989-09-01), None
patent: 2202328 (1988-09-01), None
patent: 8603782 (1986-07-01), None
patent: WO 89-09835 (1989-04-01), None
patent: 8909282 (1989-10-01), None
patent: WO 89-09835 (1989-10-01), None
patent: 8910414 (1989-11-01), None
patent: 9001069 (1990-02-01), None
patent: 9006042 (1990-06-01), None
patent: WO 90-09455 (1990-08-01), None
patent: 9011372 (1990-10-01), None
patent: WO 90-11372 (1990-10-01), None
patent: WO 89-10414 (1990-11-01), None
patent: WO 91 02087 (1991-02-01), None
patent: WO 91 13075 (1991-09-01), None
patent: WO 92 16657 (1992-10-01), None
Emi et al. Genomics. 3:373-379, Nov. 1998.
Saiki et al. Nature. 324:163-166, Nov. 1998.
Antonarakis, “Diagnosis of Genetic Disorders at the DNA Level,” N. Engl. J. Med., 320:153-163 (1989).
Bos et al., “Prevalence ofrasGene Mutations in Human Colorecta Cancers,” Nature 327:293-297 (1987).
Farr et al., “Analysis of RAS Gene Mutations in Acute Myeloid Leukemia by Polymerase Chain Reaction and Oligonucleotide Probes,” Proc. Natl. Acad. Sci. USA, 85:1629-1633 (1988).
Kaus et al.,Journal Of Clinical Investigation, 83:1095-1101, (1989).
Kerem et al., “Identification of the Cystic Fibrosis Gene: Genetic Analysis,” Science, 245:1073-1080 (1989).
Kleppe et al., “Studies on Polynucleotides,” J. Mol. Biol., 56:341-361 (1971).
Mahley, “Apolipoprotein E: Cholesterol Transport Protein With Expanding Role in Cell Biology,” Science, 240:622-630, (1988).
McLean et al., “human Apoliprotein E mRNA . . . ” J. Biol. Chem. 259:6498-6504 (1984).
McMahon et al., “Characterization of c-Ki-ras oncongene . . . ” Proc. Natl. Acad. Sci. USA, vol. 84, pp. 4974-4978 (1987).
Morel et al., “Aspartic Acid at Position 57 of the HLA-DQ B Chain Protects Against Type I Diabetes: A Family Study,” Proc. Natl. Acad. Sci. USA, 85:8111-8115, (1988).
Mullis & Faloona, “Specifi. Synthesis of DNA in vitro v.s. Polymerase-Catalyzed” Chem. Reaction. Meth. in Enzymol. 155, 335 (1987).
Mullis,Scientific American, pp. 56-65, Apr. 1990.
PCT Publication 0297379, Dattagupta, Jan. 4, 1989.
PCT Publication 0899282, Holmes, Mar. 22, 1990.
Scharf et al., “HLA Class II Allelic Variation and Susceptibility to Pemphigus Vulgaris,” Proc. Natl. Acad. Sci. USA, 85:3504-3508, (1988).
Syvanen et al., Genomics 8:684-692, (1990).
Thomson, “HLA Disease Associations: Models for Insulin Dependent Diabetes Mellitus on the Study of Complex Human Genetic Disorders,” Annu. Rev. Genet. 22:31-50, (1988).
Smith, “DNA Sequence Analysis by Primed Synthesis”, Methods in Enzymology, 65:560-581 (1980).
Kuppuswamy et al., “A New Use of Polymerase Chain Reaction (PCR) in Carrier Detection of Hemophilia-B Due to Point Mutations”, Blood, The Journal of the American Society of Hematology, Thirty-First Annual Meeting of the American Society of Hematology, 74:957 (1989).
Rommens et al., “Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping”, Science, 245:1059-1065 (1989).
Riordan et al., “Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA”, Science, 245:1066-1072 (1989).
Wu et al., “Allele-specific Enzymatic Amplification of β-Globin Genomic DNA for Diagnosis of Sickle Cell Anemia”, Proc. Natl. Acad. Sci. USA, 86:2757-2760 (1989).
Newton et al., “Analysis of Any Point Mutation in DNA. The Amplification Refractory Mutation System (ARMS)”, Nucleic Acids Research, 17:2503-2516 (1989).
Ehlen et al., “Detection of Ras Point Mutations by Polymerase Chain Reaction Using Mutation-Specific Inosine-Containing Oligonucleotide Primers”, Biochemical and Biophysical Research Communications, 160: 441-447 (1989).
Nassal et al., “PCR-Based Site-Directed Mutagenesis Using Primers With Mismatched 3′-Ends”, Nucleic Acids Research, 18:3077-3078 (1990).
Caskey et al., “Disease Diagnosis by Recombinant DNA Methods”, Science, 236:1223-1228 (1987).
Landegren et al., “DNA Diagnostics—Molecular Techniques and Automation”, Science, 242:229-237 (1988).
Rossiter et al., “Molecular Scanning Methods of Mutation Detection”, The Journal of Biological Chemistry, 265:12753-12756 (1990).
Spitzer et al., “Replacement of Isoleucine-397 by Threonine in the Clotting Proteinase Factor IXa (Los Angeles and Long Beach Variants) Affects Macromolecular Catalysis but not L-tosylarginine Methyl Ester Hydrolysis”, Biochem. J. 265:219-225 (1990).
Kuppuswamy et al., “Single Nucleotide Primer Extension to Detect Genetic Diseases: Experimental Application to Hemophilia B (factor IX) and Cystic Fibrosis Genes”, Proc. Natl. Acad. Sci. USA, 88:1143-1147 (1991).
Prober et al., “A System for Rapid DNA Sequencing With Fluorescent Chain-Terminating Dideoxynucleotides”, Science, 238:336-341 (1987).
Landegren et al., “A Ligase-Mediated Gene Detection Technique”, Science, 241:1077-1080 (1988).
Mikita et al., “Functional Consequences of the Arabinosylcytosine Structural Lesion in DNA”, Biochemist
Söderlund Hans E.
Syvanen Anne-Christine
Kalow & Springut LLP
Myers Carla J.
Orchid Cellmark Inc.
LandOfFree
Reagent kit for determining specific nucleotide variations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagent kit for determining specific nucleotide variations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagent kit for determining specific nucleotide variations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3628284